Screening of silent inflammatory bowel disease in seronegative spondyloarthritis patients: Fecal calprotectin, ileo-colonoscopy and histopathology assessment

Shaimaa Badran; Andrew Saweres; Hadeel GamalEldeen; Mohamed B. Hashem; Dalia Abdel-kareem; Fatma H. Abdelraouf; Wafaa Gaber; Tamer Elbaz

doi:10.1016/j.ejr.2023.10.001

Q3 2024

Screening of silent inflammatory bowel disease in seronegative spondyloarthritis patients: Fecal calprotectin, ileo-colonoscopy and histopathology assessment

Shaimaa Badran · Andrew Saweres · Hadeel GamalEldeen · Mohamed B. Hashem · Dalia Abdel-kareem · Fatma H. Abdelraouf · Wafaa Gaber · Tamer Elbaz

10.1016/j.ejr.2023.10.001 393 المشاهدات 4 الاقتباسات

الاقتباسات

393

المشاهدات

الملخص غير متوفر لهذا المنشور.

الاستشهاد بهذا المقال (APA)

Shaimaa, B., Andrew, S., Hadeel, G., Mohamed, B. H., Dalia, A., Fatma, H. A., Wafaa, G., Tamer, E. (2024). Screening of silent inflammatory bowel disease in seronegative spondyloarthritis patients: Fecal calprotectin, ileo-colonoscopy and histopathology assessment. Egyptian Rheumatologist. https://doi.org/10.1016/j.ejr.2023.10.001

Noha A. Fadel; Maha M. Aziz; Ghada M. Shafey; Rasha R. Rashed; Heba A. Gheita · 2024

استشهاد

388

Clinical signficance of human leucocytic antigen (HLA-B27) in patients with early and late-onset axi…

Ebru Yilmaz; Özlem Toluk · 2025

استشهاد

386

A single-center experience: Enteropathic arthritis in inflammatory bowel diseases

Barış Çabuk; Dilara Bulut Gökten; Tevfik Solakoğlu; Rafet Mete; Nurten Türkel Kü · 2024

استشهاد

384

Risk of mortality among people with rheumatoid arthritis and depression